

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 4.53787714 |
| 2 | superoxide anion generation (GO:0042554) | 4.36643391 |
| 3 | negative regulation of granulocyte differentiation (GO:0030853) | 4.10748732 |
| 4 | G-protein coupled receptor internalization (GO:0002031) | 3.71609452 |
| 5 | brown fat cell differentiation (GO:0050873) | 3.41466147 |
| 6 | white fat cell differentiation (GO:0050872) | 3.40994790 |
| 7 | acylglycerol catabolic process (GO:0046464) | 3.34064499 |
| 8 | neutral lipid catabolic process (GO:0046461) | 3.34064499 |
| 9 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.27716926 |
| 10 | import into cell (GO:0098657) | 3.11326396 |
| 11 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.02749465 |
| 12 | positive regulation of heat generation (GO:0031652) | 2.96534318 |
| 13 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.94086828 |
| 14 | fatty acid homeostasis (GO:0055089) | 2.92359602 |
| 15 | cellular response to epinephrine stimulus (GO:0071872) | 2.89308561 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.85458666 |
| 17 | low-density lipoprotein particle clearance (GO:0034383) | 2.84076798 |
| 18 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.84004526 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.80567004 |
| 20 | negative regulation of protein autophosphorylation (GO:0031953) | 2.80123840 |
| 21 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.78539245 |
| 22 | ethanol oxidation (GO:0006069) | 2.77428904 |
| 23 | lipid storage (GO:0019915) | 2.76621970 |
| 24 | negative regulation of fatty acid transport (GO:2000192) | 2.72235564 |
| 25 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.72171212 |
| 26 | protein carboxylation (GO:0018214) | 2.71486549 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.71486549 |
| 28 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.70733249 |
| 29 | response to epinephrine (GO:0071871) | 2.70329045 |
| 30 | cAMP catabolic process (GO:0006198) | 2.67210360 |
| 31 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.65580355 |
| 32 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.64119033 |
| 33 | biotin metabolic process (GO:0006768) | 2.63988326 |
| 34 | glycerolipid catabolic process (GO:0046503) | 2.63045147 |
| 35 | plasma lipoprotein particle clearance (GO:0034381) | 2.59373836 |
| 36 | cyclic nucleotide catabolic process (GO:0009214) | 2.59097314 |
| 37 | histone H3-K36 demethylation (GO:0070544) | 2.57231408 |
| 38 | positive regulation of glucose import (GO:0046326) | 2.56079551 |
| 39 | negative regulation of lipid storage (GO:0010888) | 2.55665824 |
| 40 | superoxide metabolic process (GO:0006801) | 2.54616984 |
| 41 | complement activation, alternative pathway (GO:0006957) | 2.53352018 |
| 42 | polyol transport (GO:0015791) | 2.52417028 |
| 43 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.50770184 |
| 44 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.50656347 |
| 45 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.50467463 |
| 46 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.49477844 |
| 47 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.48124996 |
| 48 | response to host immune response (GO:0052572) | 2.48124996 |
| 49 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.47557709 |
| 50 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.46409336 |
| 51 | diacylglycerol metabolic process (GO:0046339) | 2.46405850 |
| 52 | adrenergic receptor signaling pathway (GO:0071875) | 2.45576782 |
| 53 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.45253046 |
| 54 | regulation of cholesterol homeostasis (GO:2000188) | 2.45126870 |
| 55 | positive regulation of fatty acid oxidation (GO:0046321) | 2.44850458 |
| 56 | daunorubicin metabolic process (GO:0044597) | 2.43904344 |
| 57 | polyketide metabolic process (GO:0030638) | 2.43904344 |
| 58 | doxorubicin metabolic process (GO:0044598) | 2.43904344 |
| 59 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.43151812 |
| 60 | macroautophagy (GO:0016236) | 2.40952662 |
| 61 | limb bud formation (GO:0060174) | 2.40584054 |
| 62 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.40332321 |
| 63 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.38901147 |
| 64 | myelination in peripheral nervous system (GO:0022011) | 2.38816694 |
| 65 | peripheral nervous system axon ensheathment (GO:0032292) | 2.38816694 |
| 66 | histone H3-K4 trimethylation (GO:0080182) | 2.38474273 |
| 67 | positive regulation of glucose transport (GO:0010828) | 2.38181066 |
| 68 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.37447542 |
| 69 | negative regulation of gluconeogenesis (GO:0045721) | 2.36408489 |
| 70 | regulation of heat generation (GO:0031650) | 2.36262862 |
| 71 | regulation of protein activation cascade (GO:2000257) | 2.35516015 |
| 72 | regulation of complement activation (GO:0030449) | 2.35296932 |
| 73 | positive regulation of cholesterol efflux (GO:0010875) | 2.34267014 |
| 74 | activation of protein kinase A activity (GO:0034199) | 2.33797189 |
| 75 | cGMP-mediated signaling (GO:0019934) | 2.32939704 |
| 76 | glycine transport (GO:0015816) | 2.32816926 |
| 77 | regulation of pigment cell differentiation (GO:0050932) | 2.32458972 |
| 78 | protein heterotrimerization (GO:0070208) | 2.30154126 |
| 79 | positive regulation of glycolytic process (GO:0045821) | 2.29427603 |
| 80 | startle response (GO:0001964) | 2.28933070 |
| 81 | response to dietary excess (GO:0002021) | 2.27627050 |
| 82 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.27508727 |
| 83 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.26763010 |
| 84 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.26082238 |
| 85 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.26082238 |
| 86 | triglyceride homeostasis (GO:0070328) | 2.25959523 |
| 87 | acylglycerol homeostasis (GO:0055090) | 2.25959523 |
| 88 | regulation of cholesterol storage (GO:0010885) | 2.25908992 |
| 89 | mesenchymal cell differentiation (GO:0048762) | 2.25586051 |
| 90 | presynaptic membrane assembly (GO:0097105) | 2.25524051 |
| 91 | response to catecholamine (GO:0071869) | 2.25503709 |
| 92 | response to monoamine (GO:0071867) | 2.25503709 |
| 93 | response to folic acid (GO:0051593) | 2.24278264 |
| 94 | regulation of germinal center formation (GO:0002634) | 2.24094351 |
| 95 | carnitine shuttle (GO:0006853) | 2.24027262 |
| 96 | regulation of fatty acid oxidation (GO:0046320) | 2.23703062 |
| 97 | positive regulation of NIK/NF-kappaB signaling (GO:1901224) | 2.23258546 |
| 98 | fatty acid transmembrane transport (GO:1902001) | 2.22841028 |
| 99 | ovulation from ovarian follicle (GO:0001542) | 2.22414233 |
| 100 | positive regulation of lipid storage (GO:0010884) | 2.22163708 |
| 101 | detection of molecule of bacterial origin (GO:0032490) | 2.21822266 |
| 102 | mitochondrion distribution (GO:0048311) | 2.21075565 |
| 103 | righting reflex (GO:0060013) | 2.20584974 |
| 104 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.19889338 |
| 105 | regulation of activation of Janus kinase activity (GO:0010533) | 2.19261663 |
| 106 | retina layer formation (GO:0010842) | 2.19144086 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 2.18103502 |
| 108 | detection of other organism (GO:0098543) | 2.17598611 |
| 109 | negative regulation of vascular permeability (GO:0043116) | 2.17555719 |
| 110 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.17537540 |
| 111 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.16766253 |
| 112 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.16363504 |
| 113 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.16363504 |
| 114 | modulation by symbiont of host immune response (GO:0052553) | 2.16363504 |
| 115 | positive regulation by symbiont of host defense response (GO:0052509) | 2.16363504 |
| 116 | modulation by symbiont of host defense response (GO:0052031) | 2.16363504 |
| 117 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.16363504 |
| 118 | detection of calcium ion (GO:0005513) | 2.15817977 |
| 119 | energy homeostasis (GO:0097009) | 2.15496157 |
| 120 | endocrine hormone secretion (GO:0060986) | 2.14893022 |
| 121 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.14717544 |
| 122 | camera-type eye morphogenesis (GO:0048593) | 2.14626894 |
| 123 | reflex (GO:0060004) | 2.14326084 |
| 124 | prostate gland growth (GO:0060736) | 2.13951895 |
| 125 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.13802893 |
| 126 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.12909527 |
| 127 | negative regulation of phagocytosis (GO:0050765) | 2.12822348 |
| 128 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.12666286 |
| 129 | response to host (GO:0075136) | 2.12666286 |
| 130 | response to host defenses (GO:0052200) | 2.12666286 |
| 131 | negative regulation of protein activation cascade (GO:2000258) | 2.12568677 |
| 132 | extracellular regulation of signal transduction (GO:1900115) | 2.11721799 |
| 133 | extracellular negative regulation of signal transduction (GO:1900116) | 2.11721799 |
| 134 | carnitine transmembrane transport (GO:1902603) | 2.10919775 |
| 135 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.10887251 |
| 136 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.10765249 |
| 137 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.10582314 |
| 138 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.10517974 |
| 139 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.10158168 |
| 140 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.10157317 |
| 141 | positive regulation of sterol transport (GO:0032373) | 2.09812420 |
| 142 | positive regulation of cholesterol transport (GO:0032376) | 2.09812420 |
| 143 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.09442280 |
| 144 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.09163224 |
| 145 | regulation of NIK/NF-kappaB signaling (GO:1901222) | 2.08859780 |
| 146 | response to lipoprotein particle (GO:0055094) | 2.08755194 |
| 147 | negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744) | 2.07706900 |
| 148 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.07603702 |
| 149 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.07220580 |
| 150 | ethanol metabolic process (GO:0006067) | 2.07173372 |
| 151 | cell communication by electrical coupling (GO:0010644) | 2.06385373 |
| 152 | negative regulation of complement activation (GO:0045916) | 2.06012914 |
| 153 | positive regulation of protein kinase C signaling (GO:0090037) | 2.05884012 |
| 154 | urea metabolic process (GO:0019627) | 2.05772247 |
| 155 | regulation of granulocyte differentiation (GO:0030852) | 2.05418347 |
| 156 | regulation of lipid catabolic process (GO:0050994) | 2.05026057 |
| 157 | cellular response to monoamine stimulus (GO:0071868) | 2.04951742 |
| 158 | cellular response to catecholamine stimulus (GO:0071870) | 2.04951742 |
| 159 | L-amino acid import (GO:0043092) | 2.04792838 |
| 160 | triglyceride catabolic process (GO:0019433) | 2.03933528 |
| 161 | cardiac myofibril assembly (GO:0055003) | 2.03841755 |
| 162 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.03014687 |
| 163 | glomerular basement membrane development (GO:0032836) | 2.02678791 |
| 164 | neuronal ion channel clustering (GO:0045161) | 2.02180377 |
| 165 | urea cycle (GO:0000050) | 2.01171332 |
| 166 | carnitine transport (GO:0015879) | 2.00545991 |
| 167 | amino-acid betaine transport (GO:0015838) | 2.00545991 |
| 168 | regulation of triglyceride biosynthetic process (GO:0010866) | 1.99838724 |
| 169 | negative regulation of lipase activity (GO:0060192) | 1.99301664 |
| 170 | fibroblast migration (GO:0010761) | 1.96842289 |
| 171 | cellular sodium ion homeostasis (GO:0006883) | 1.96799448 |
| 172 | growth hormone receptor signaling pathway (GO:0060396) | 1.96377371 |
| 173 | sodium ion export (GO:0071436) | 1.95510187 |
| 174 | cellular potassium ion homeostasis (GO:0030007) | 1.95011730 |
| 175 | negative regulation of lipid transport (GO:0032369) | 1.93992024 |
| 176 | myofibril assembly (GO:0030239) | 1.93691095 |
| 177 | glomerular filtration (GO:0003094) | 1.92405144 |
| 178 | negative regulation of Rho protein signal transduction (GO:0035024) | 1.91249717 |
| 179 | metanephric tubule development (GO:0072170) | 1.90865456 |
| 180 | metanephric nephron tubule development (GO:0072234) | 1.90865456 |
| 181 | cellular response to growth hormone stimulus (GO:0071378) | 1.90189812 |
| 182 | cell migration involved in heart development (GO:0060973) | 1.89367396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.02418578 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.54669792 |
| 3 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.41185543 |
| 4 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.35655296 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.34503863 |
| 6 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.18047256 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.14954858 |
| 8 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.10568184 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.07292967 |
| 10 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.05850726 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.02977776 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.97663651 |
| 13 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.95677956 |
| 14 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.95385001 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.94591504 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.93666532 |
| 17 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.92641877 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.83633741 |
| 19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.83112913 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81947762 |
| 21 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.80188914 |
| 22 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.79001444 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76158531 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.76016599 |
| 25 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74936871 |
| 26 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.74906769 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.74804636 |
| 28 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.74754791 |
| 29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.72316909 |
| 30 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.71905166 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.70989995 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.70623679 |
| 33 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.69171131 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.69168249 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68965633 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.68393867 |
| 37 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.68297560 |
| 38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.67646543 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66935257 |
| 40 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.66658867 |
| 41 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.65793964 |
| 42 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.65263618 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.60610284 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59056655 |
| 45 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59021924 |
| 46 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58242270 |
| 47 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.56465088 |
| 48 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.55708197 |
| 49 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.54999013 |
| 50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.54099747 |
| 51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53907782 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53824706 |
| 53 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.52258627 |
| 54 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.50811381 |
| 55 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.50395624 |
| 56 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.49851531 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.49415915 |
| 58 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.47946428 |
| 59 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.47946428 |
| 60 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.47661875 |
| 61 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.47356853 |
| 62 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.47042396 |
| 63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.46514414 |
| 64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.46212728 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.44836492 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44679072 |
| 67 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.44189310 |
| 68 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.42799515 |
| 69 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41902255 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.41604639 |
| 71 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.40832639 |
| 72 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.40653576 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39809719 |
| 74 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.39686162 |
| 75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38852095 |
| 76 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37735689 |
| 77 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.36211892 |
| 78 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33979059 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32940941 |
| 80 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.32379592 |
| 81 | TCF4_23295773_ChIP-Seq_U87_Human | 1.32139767 |
| 82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31981786 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.31868574 |
| 84 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.31720659 |
| 85 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.31603243 |
| 86 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31295416 |
| 87 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.30977713 |
| 88 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.30964739 |
| 89 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30356734 |
| 90 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.30052641 |
| 91 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.29901408 |
| 92 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.29294862 |
| 93 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.29169551 |
| 94 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28998833 |
| 95 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.28324487 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28002223 |
| 97 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27811123 |
| 98 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.26935844 |
| 99 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.25954526 |
| 100 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.25657293 |
| 101 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.25657293 |
| 102 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25344628 |
| 103 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25291642 |
| 104 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24210542 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24169883 |
| 106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23883397 |
| 107 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.23346434 |
| 108 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23035653 |
| 109 | KDM2B_26808549_Chip-Seq_REH_Human | 1.22748381 |
| 110 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21453388 |
| 111 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.21438279 |
| 112 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.20418019 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19662210 |
| 114 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19522721 |
| 115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19504680 |
| 116 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.19478571 |
| 117 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19478571 |
| 118 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.19377233 |
| 119 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18989204 |
| 120 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.18970802 |
| 121 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18355735 |
| 122 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18228497 |
| 123 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18212691 |
| 124 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17910952 |
| 125 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17711925 |
| 126 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17442378 |
| 127 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.16913069 |
| 128 | FUS_26573619_Chip-Seq_HEK293_Human | 1.16294896 |
| 129 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15504138 |
| 130 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15329965 |
| 131 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14696955 |
| 132 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14428170 |
| 133 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.14110324 |
| 134 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.13557091 |
| 135 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13395095 |
| 136 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12316534 |
| 137 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12144390 |
| 138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10721043 |
| 139 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10698886 |
| 140 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09204589 |
| 141 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08551571 |
| 142 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.07997506 |
| 143 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06536170 |
| 144 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05810041 |
| 145 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05487162 |
| 146 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04893908 |
| 147 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03880027 |
| 148 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.02623122 |
| 149 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00062595 |
| 150 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96367506 |
| 151 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96367506 |
| 152 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96260387 |
| 153 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95638138 |
| 154 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94282721 |
| 155 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94072101 |
| 156 | AR_19668381_ChIP-Seq_PC3_Human | 0.93528824 |
| 157 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90082659 |
| 158 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89770853 |
| 159 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88692873 |
| 160 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88180973 |
| 161 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87743058 |
| 162 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87710453 |
| 163 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.87538440 |
| 164 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85629112 |
| 165 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.85297584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 6.78902393 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.80269992 |
| 3 | MP0002876_abnormal_thyroid_physiology | 3.43518980 |
| 4 | MP0005666_abnormal_adipose_tissue | 3.29247697 |
| 5 | MP0001188_hyperpigmentation | 3.23081902 |
| 6 | MP0005645_abnormal_hypothalamus_physiol | 2.86769084 |
| 7 | MP0002102_abnormal_ear_morphology | 2.60828681 |
| 8 | MP0000751_myopathy | 2.43901852 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.42856871 |
| 10 | MP0004130_abnormal_muscle_cell | 2.30011015 |
| 11 | MP0004185_abnormal_adipocyte_glucose | 2.28049343 |
| 12 | MP0003045_fibrosis | 2.16694175 |
| 13 | MP0005375_adipose_tissue_phenotype | 2.14440812 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.13262201 |
| 15 | MP0010368_abnormal_lymphatic_system | 2.12647908 |
| 16 | MP0004272_abnormal_basement_membrane | 2.06306217 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.01753237 |
| 18 | MP0005409_darkened_coat_color | 1.97177290 |
| 19 | MP0006138_congestive_heart_failure | 1.93635365 |
| 20 | MP0002971_abnormal_brown_adipose | 1.88667324 |
| 21 | MP0003724_increased_susceptibility_to | 1.87041413 |
| 22 | MP0003787_abnormal_imprinting | 1.81071181 |
| 23 | MP0000566_synostosis | 1.80923358 |
| 24 | MP0005171_absent_coat_pigmentation | 1.76941198 |
| 25 | MP0001501_abnormal_sleep_pattern | 1.73559118 |
| 26 | MP0009115_abnormal_fat_cell | 1.70747527 |
| 27 | MP0005334_abnormal_fat_pad | 1.69547225 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.68659634 |
| 29 | MP0001958_emphysema | 1.68516460 |
| 30 | MP0006292_abnormal_olfactory_placode | 1.67925713 |
| 31 | MP0003136_yellow_coat_color | 1.66112998 |
| 32 | MP0003868_abnormal_feces_composition | 1.64994047 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.59693389 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.57099705 |
| 35 | MP0001486_abnormal_startle_reflex | 1.56399846 |
| 36 | MP0000383_abnormal_hair_follicle | 1.53502009 |
| 37 | MP0005365_abnormal_bile_salt | 1.52882898 |
| 38 | MP0003283_abnormal_digestive_organ | 1.52125027 |
| 39 | MP0002277_abnormal_respiratory_mucosa | 1.51967724 |
| 40 | MP0004742_abnormal_vestibular_system | 1.47214707 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.45868482 |
| 42 | MP0004381_abnormal_hair_follicle | 1.43525759 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.42480519 |
| 44 | MP0003950_abnormal_plasma_membrane | 1.42244112 |
| 45 | MP0004087_abnormal_muscle_fiber | 1.34435148 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.32489487 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 1.32440694 |
| 48 | MP0005535_abnormal_body_temperature | 1.32017992 |
| 49 | MP0003195_calcinosis | 1.31838595 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.29887657 |
| 51 | MP0002009_preneoplasia | 1.29312039 |
| 52 | MP0004215_abnormal_myocardial_fiber | 1.28698318 |
| 53 | MP0001661_extended_life_span | 1.28015134 |
| 54 | MP0003279_aneurysm | 1.27653295 |
| 55 | MP0003091_abnormal_cell_migration | 1.26189933 |
| 56 | MP0004484_altered_response_of | 1.26083496 |
| 57 | MP0005379_endocrine/exocrine_gland_phen | 1.24883252 |
| 58 | MP0004084_abnormal_cardiac_muscle | 1.24270004 |
| 59 | MP0004036_abnormal_muscle_relaxation | 1.22853008 |
| 60 | MP0003879_abnormal_hair_cell | 1.22624319 |
| 61 | MP0000427_abnormal_hair_cycle | 1.20972450 |
| 62 | MP0004859_abnormal_synaptic_plasticity | 1.20962306 |
| 63 | MP0005423_abnormal_somatic_nervous | 1.17004378 |
| 64 | MP0005595_abnormal_vascular_smooth | 1.16434615 |
| 65 | MP0003828_pulmonary_edema | 1.14475824 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.13312745 |
| 67 | MP0002295_abnormal_pulmonary_circulatio | 1.09069456 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.07645947 |
| 69 | MP0001835_abnormal_antigen_presentation | 1.05911374 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.05097473 |
| 71 | MP0002735_abnormal_chemical_nociception | 1.04949731 |
| 72 | MP0003329_amyloid_beta_deposits | 1.04684025 |
| 73 | MP0005620_abnormal_muscle_contractility | 1.04292546 |
| 74 | MP0002168_other_aberrant_phenotype | 1.03162774 |
| 75 | MP0009046_muscle_twitch | 1.02478793 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 1.02347946 |
| 77 | MP0004270_analgesia | 1.02079366 |
| 78 | MP0009764_decreased_sensitivity_to | 1.01655422 |
| 79 | MP0000759_abnormal_skeletal_muscle | 1.01302270 |
| 80 | MP0001790_abnormal_immune_system | 1.00977660 |
| 81 | MP0005387_immune_system_phenotype | 1.00977660 |
| 82 | MP0000747_muscle_weakness | 0.99217512 |
| 83 | MP0000026_abnormal_inner_ear | 0.98685533 |
| 84 | MP0002254_reproductive_system_inflammat | 0.96931419 |
| 85 | MP0003690_abnormal_glial_cell | 0.95713748 |
| 86 | MP0000579_abnormal_nail_morphology | 0.95600328 |
| 87 | MP0002896_abnormal_bone_mineralization | 0.95589681 |
| 88 | MP0002006_tumorigenesis | 0.95094471 |
| 89 | MP0005451_abnormal_body_composition | 0.95036341 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.94506803 |
| 91 | MP0005647_abnormal_sex_gland | 0.93397690 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.93243400 |
| 93 | MP0001177_atelectasis | 0.92632451 |
| 94 | MP0000767_abnormal_smooth_muscle | 0.90918478 |
| 95 | MP0002166_altered_tumor_susceptibility | 0.89777718 |
| 96 | MP0010630_abnormal_cardiac_muscle | 0.89639957 |
| 97 | MP0002419_abnormal_innate_immunity | 0.88735075 |
| 98 | MP0003959_abnormal_lean_body | 0.88730787 |
| 99 | MP0003941_abnormal_skin_development | 0.87471395 |
| 100 | MP0001299_abnormal_eye_distance/ | 0.87031476 |
| 101 | MP0005253_abnormal_eye_physiology | 0.86865038 |
| 102 | MP0005448_abnormal_energy_balance | 0.86471215 |
| 103 | MP0010386_abnormal_urinary_bladder | 0.85833012 |
| 104 | MP0009697_abnormal_copulation | 0.85739218 |
| 105 | MP0002837_dystrophic_cardiac_calcinosis | 0.85540090 |
| 106 | MP0001502_abnormal_circadian_rhythm | 0.85515834 |
| 107 | MP0005385_cardiovascular_system_phenoty | 0.84676413 |
| 108 | MP0001544_abnormal_cardiovascular_syste | 0.84676413 |
| 109 | MP0001346_abnormal_lacrimal_gland | 0.84308690 |
| 110 | MP0002249_abnormal_larynx_morphology | 0.84280664 |
| 111 | MP0004858_abnormal_nervous_system | 0.84267472 |
| 112 | MP0002148_abnormal_hypersensitivity_rea | 0.84108897 |
| 113 | MP0002108_abnormal_muscle_morphology | 0.83024448 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.82877578 |
| 115 | MP0000733_abnormal_muscle_development | 0.82413764 |
| 116 | MP0005275_abnormal_skin_tensile | 0.82304268 |
| 117 | MP0001963_abnormal_hearing_physiology | 0.81430883 |
| 118 | MP0002060_abnormal_skin_morphology | 0.80608904 |
| 119 | MP0009840_abnormal_foam_cell | 0.80300397 |
| 120 | MP0004510_myositis | 0.79684251 |
| 121 | MP0009384_cardiac_valve_regurgitation | 0.78890036 |
| 122 | MP0002972_abnormal_cardiac_muscle | 0.77456636 |
| 123 | MP0000681_abnormal_thyroid_gland | 0.77370625 |
| 124 | MP0002063_abnormal_learning/memory/cond | 0.77293950 |
| 125 | MP0003011_delayed_dark_adaptation | 0.77260029 |
| 126 | MP0005452_abnormal_adipose_tissue | 0.76682165 |
| 127 | MP0003948_abnormal_gas_homeostasis | 0.76400297 |
| 128 | MP0004085_abnormal_heartbeat | 0.75494889 |
| 129 | MP0005369_muscle_phenotype | 0.74892264 |
| 130 | MP0003635_abnormal_synaptic_transmissio | 0.74716223 |
| 131 | MP0004782_abnormal_surfactant_physiolog | 0.73852584 |
| 132 | MP0005257_abnormal_intraocular_pressure | 0.72569832 |
| 133 | MP0009785_altered_susceptibility_to | 0.72415544 |
| 134 | MP0005503_abnormal_tendon_morphology | 0.71842665 |
| 135 | MP0005085_abnormal_gallbladder_physiolo | 0.71726741 |
| 136 | MP0000013_abnormal_adipose_tissue | 0.71523027 |
| 137 | MP0005623_abnormal_meninges_morphology | 0.71173177 |
| 138 | MP0005330_cardiomyopathy | 0.70924723 |
| 139 | MP0008260_abnormal_autophagy | 0.70763533 |
| 140 | MP0002067_abnormal_sensory_capabilities | 0.70155081 |
| 141 | MP0005671_abnormal_response_to | 0.69808562 |
| 142 | MP0002064_seizures | 0.69800539 |
| 143 | MP0002928_abnormal_bile_duct | 0.69387402 |
| 144 | MP0002970_abnormal_white_adipose | 0.69026876 |
| 145 | MP0002128_abnormal_blood_circulation | 0.68501579 |
| 146 | MP0000749_muscle_degeneration | 0.68063971 |
| 147 | MP0000778_abnormal_nervous_system | 0.67816159 |
| 148 | MP0003953_abnormal_hormone_level | 0.67355297 |
| 149 | MP0003942_abnormal_urinary_system | 0.66854445 |
| 150 | MP0008875_abnormal_xenobiotic_pharmacok | 0.66674734 |
| 151 | MP0009780_abnormal_chondrocyte_physiolo | 0.64676127 |
| 152 | MP0010678_abnormal_skin_adnexa | 0.63651773 |
| 153 | MP0008775_abnormal_heart_ventricle | 0.62179675 |
| 154 | MP0009745_abnormal_behavioral_response | 0.61457481 |
| 155 | MP0001879_abnormal_lymphatic_vessel | 0.56861256 |
| 156 | MP0008004_abnormal_stomach_pH | 0.56460232 |
| 157 | MP0006276_abnormal_autonomic_nervous | 0.54979124 |
| 158 | MP0004134_abnormal_chest_morphology | 0.54675130 |
| 159 | MP0000371_diluted_coat_color | 0.54429676 |
| 160 | MP0004147_increased_porphyrin_level | 0.53768285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 5.10811100 |
| 2 | Chromsome breakage (HP:0040012) | 4.47285151 |
| 3 | Prostate neoplasm (HP:0100787) | 3.95997524 |
| 4 | Duplicated collecting system (HP:0000081) | 3.83194058 |
| 5 | Febrile seizures (HP:0002373) | 3.77549251 |
| 6 | Abnormality of the renal collecting system (HP:0004742) | 3.54826057 |
| 7 | Protrusio acetabuli (HP:0003179) | 3.51201363 |
| 8 | Complement deficiency (HP:0004431) | 3.49835764 |
| 9 | Upper limb muscle weakness (HP:0003484) | 3.18511986 |
| 10 | Oligomenorrhea (HP:0000876) | 3.01622977 |
| 11 | Thyroid-stimulating hormone excess (HP:0002925) | 3.00910897 |
| 12 | Abnormality of incisor morphology (HP:0011063) | 2.95436271 |
| 13 | Renal cortical cysts (HP:0000803) | 2.94638416 |
| 14 | Mesomelia (HP:0003027) | 2.92456882 |
| 15 | Aplasia cutis congenita (HP:0001057) | 2.91354410 |
| 16 | Broad metatarsal (HP:0001783) | 2.91097593 |
| 17 | Abnormality of the nasal septum (HP:0000419) | 2.86249725 |
| 18 | Abnormality of complement system (HP:0005339) | 2.79670703 |
| 19 | Aortic aneurysm (HP:0004942) | 2.78933673 |
| 20 | Septo-optic dysplasia (HP:0100842) | 2.77319430 |
| 21 | Turricephaly (HP:0000262) | 2.75774751 |
| 22 | Mitral stenosis (HP:0001718) | 2.73205892 |
| 23 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.73090906 |
| 24 | Absent/shortened dynein arms (HP:0200106) | 2.73090906 |
| 25 | Shallow orbits (HP:0000586) | 2.72300220 |
| 26 | Alveolar cell carcinoma (HP:0006519) | 2.70831529 |
| 27 | Increased variability in muscle fiber diameter (HP:0003557) | 2.70543727 |
| 28 | Chronic hepatic failure (HP:0100626) | 2.68828720 |
| 29 | Congenital sensorineural hearing impairment (HP:0008527) | 2.68409886 |
| 30 | Bronchomalacia (HP:0002780) | 2.66905701 |
| 31 | Overgrowth (HP:0001548) | 2.64809728 |
| 32 | Congenital stationary night blindness (HP:0007642) | 2.63048098 |
| 33 | Abnormal ciliary motility (HP:0012262) | 2.58848512 |
| 34 | Vascular tortuosity (HP:0004948) | 2.54438657 |
| 35 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.53914523 |
| 36 | Tubulointerstitial nephritis (HP:0001970) | 2.53842169 |
| 37 | Coronal craniosynostosis (HP:0004440) | 2.53061360 |
| 38 | Oligodactyly (hands) (HP:0001180) | 2.52159331 |
| 39 | Difficulty running (HP:0009046) | 2.49101610 |
| 40 | Pigmentary retinal degeneration (HP:0001146) | 2.47969145 |
| 41 | Hemorrhage of the eye (HP:0011885) | 2.46647381 |
| 42 | Cerebral aneurysm (HP:0004944) | 2.43735291 |
| 43 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.43155523 |
| 44 | Ulnar bowing (HP:0003031) | 2.41554963 |
| 45 | Dysmetric saccades (HP:0000641) | 2.38431308 |
| 46 | Arterial tortuosity (HP:0005116) | 2.37616467 |
| 47 | Hyperlipoproteinemia (HP:0010980) | 2.37027805 |
| 48 | Obstructive sleep apnea (HP:0002870) | 2.36507865 |
| 49 | Decreased central vision (HP:0007663) | 2.36415689 |
| 50 | Acanthosis nigricans (HP:0000956) | 2.29028844 |
| 51 | Hyporeflexia of lower limbs (HP:0002600) | 2.28232755 |
| 52 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.24758117 |
| 53 | Abnormality of the renal cortex (HP:0011035) | 2.24486934 |
| 54 | Fair hair (HP:0002286) | 2.24159524 |
| 55 | Aplasia of the phalanges of the hand (HP:0009802) | 2.23750553 |
| 56 | Aplasia involving bones of the extremities (HP:0009825) | 2.23750553 |
| 57 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.23750553 |
| 58 | Increased connective tissue (HP:0009025) | 2.22876285 |
| 59 | Joint hemorrhage (HP:0005261) | 2.21475875 |
| 60 | White forelock (HP:0002211) | 2.21352821 |
| 61 | Skin nodule (HP:0200036) | 2.20899662 |
| 62 | Xanthomatosis (HP:0000991) | 2.19362140 |
| 63 | Long foot (HP:0001833) | 2.18942188 |
| 64 | Deep venous thrombosis (HP:0002625) | 2.17237977 |
| 65 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.16464161 |
| 66 | Abnormality of DNA repair (HP:0003254) | 2.16012552 |
| 67 | Abnormality of the ischium (HP:0003174) | 2.15075112 |
| 68 | Optic neuritis (HP:0100653) | 2.13597264 |
| 69 | Retrobulbar optic neuritis (HP:0100654) | 2.13597264 |
| 70 | Type 1 muscle fiber predominance (HP:0003803) | 2.13453491 |
| 71 | Hypoplasia of the iris (HP:0007676) | 2.12270379 |
| 72 | Spinal rigidity (HP:0003306) | 2.09563123 |
| 73 | Submucous cleft hard palate (HP:0000176) | 2.08364076 |
| 74 | Clubbing of toes (HP:0100760) | 2.07570546 |
| 75 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.06047955 |
| 76 | Hypertriglyceridemia (HP:0002155) | 2.06044216 |
| 77 | Wormian bones (HP:0002645) | 2.05922695 |
| 78 | Atrioventricular block (HP:0001678) | 2.03489902 |
| 79 | Abnormality of the fingertips (HP:0001211) | 2.02063394 |
| 80 | Recurrent cutaneous fungal infections (HP:0011370) | 2.01252735 |
| 81 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.01252735 |
| 82 | Premature rupture of membranes (HP:0001788) | 1.99414653 |
| 83 | Pulmonary artery stenosis (HP:0004415) | 1.99264068 |
| 84 | Mitral valve prolapse (HP:0001634) | 1.99041934 |
| 85 | Renovascular hypertension (HP:0100817) | 1.98650445 |
| 86 | Focal motor seizures (HP:0011153) | 1.98511339 |
| 87 | Generalized hypopigmentation of hair (HP:0011358) | 1.98440045 |
| 88 | Duplication of thumb phalanx (HP:0009942) | 1.98425996 |
| 89 | Abnormality of the renal medulla (HP:0100957) | 1.97854555 |
| 90 | Bladder diverticulum (HP:0000015) | 1.97791958 |
| 91 | Glomerulonephritis (HP:0000099) | 1.97716183 |
| 92 | Patchy hypopigmentation of hair (HP:0011365) | 1.96908764 |
| 93 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.96410139 |
| 94 | Optic nerve hypoplasia (HP:0000609) | 1.96311457 |
| 95 | Conical tooth (HP:0000698) | 1.96086347 |
| 96 | Aortic dissection (HP:0002647) | 1.95908413 |
| 97 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.94764485 |
| 98 | Vertebral arch anomaly (HP:0008438) | 1.92857036 |
| 99 | Attenuation of retinal blood vessels (HP:0007843) | 1.92713825 |
| 100 | Bundle branch block (HP:0011710) | 1.92144199 |
| 101 | Asymmetric septal hypertrophy (HP:0001670) | 1.91130731 |
| 102 | Nephronophthisis (HP:0000090) | 1.91025010 |
| 103 | Protruding tongue (HP:0010808) | 1.90453286 |
| 104 | Muscle fiber splitting (HP:0003555) | 1.89652027 |
| 105 | Abnormality of the common coagulation pathway (HP:0010990) | 1.89144230 |
| 106 | Action tremor (HP:0002345) | 1.88614146 |
| 107 | Neonatal hypoglycemia (HP:0001998) | 1.88186184 |
| 108 | Congenital hepatic fibrosis (HP:0002612) | 1.88101695 |
| 109 | Hypothermia (HP:0002045) | 1.86795423 |
| 110 | Wide anterior fontanel (HP:0000260) | 1.86364135 |
| 111 | Increased corneal curvature (HP:0100692) | 1.85642543 |
| 112 | Keratoconus (HP:0000563) | 1.85642543 |
| 113 | Blue irides (HP:0000635) | 1.84822243 |
| 114 | Bell-shaped thorax (HP:0001591) | 1.84696946 |
| 115 | Hypercholesterolemia (HP:0003124) | 1.84477628 |
| 116 | Hypoalphalipoproteinemia (HP:0003233) | 1.84380223 |
| 117 | Distal lower limb amyotrophy (HP:0008944) | 1.84282511 |
| 118 | Abnormal atrioventricular conduction (HP:0005150) | 1.84021308 |
| 119 | Insulin resistance (HP:0000855) | 1.83960855 |
| 120 | Lip pit (HP:0100267) | 1.83596568 |
| 121 | Chronic diarrhea (HP:0002028) | 1.82908911 |
| 122 | Ectropion (HP:0000656) | 1.82489526 |
| 123 | Frequent falls (HP:0002359) | 1.82232424 |
| 124 | Absent speech (HP:0001344) | 1.82129224 |
| 125 | Absent frontal sinuses (HP:0002688) | 1.81642106 |
| 126 | Striae distensae (HP:0001065) | 1.81475996 |
| 127 | Cerebral inclusion bodies (HP:0100314) | 1.81259162 |
| 128 | Bradycardia (HP:0001662) | 1.80901205 |
| 129 | Atrial fibrillation (HP:0005110) | 1.80877258 |
| 130 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79814461 |
| 131 | Limited hip movement (HP:0008800) | 1.79798249 |
| 132 | Aneurysm (HP:0002617) | 1.79169024 |
| 133 | Nephritis (HP:0000123) | 1.79063759 |
| 134 | Exercise-induced myalgia (HP:0003738) | 1.77427538 |
| 135 | Prolonged partial thromboplastin time (HP:0003645) | 1.76491033 |
| 136 | Postaxial foot polydactyly (HP:0001830) | 1.76191992 |
| 137 | Abnormality of the carotid arteries (HP:0005344) | 1.75902147 |
| 138 | Back pain (HP:0003418) | 1.75818409 |
| 139 | Heart block (HP:0012722) | 1.74805724 |
| 140 | Gingivitis (HP:0000230) | 1.73904612 |
| 141 | Macroorchidism (HP:0000053) | 1.73025639 |
| 142 | Myotonia (HP:0002486) | 1.71856151 |
| 143 | Hypercortisolism (HP:0001578) | 1.71577813 |
| 144 | Craniofacial hyperostosis (HP:0004493) | 1.70904687 |
| 145 | Tracheomalacia (HP:0002779) | 1.70056968 |
| 146 | Anal stenosis (HP:0002025) | 1.69619998 |
| 147 | Neurofibrillary tangles (HP:0002185) | 1.69455423 |
| 148 | Epidermoid cyst (HP:0200040) | 1.68385541 |
| 149 | Distal lower limb muscle weakness (HP:0009053) | 1.67327997 |
| 150 | Exotropia (HP:0000577) | 1.67158003 |
| 151 | Hyperacusis (HP:0010780) | 1.66840551 |
| 152 | Abnormality of the prostate (HP:0008775) | 1.66711945 |
| 153 | Nasolacrimal duct obstruction (HP:0000579) | 1.66189015 |
| 154 | Abnormality of the intrinsic pathway (HP:0010989) | 1.66098199 |
| 155 | Neonatal short-limb short stature (HP:0008921) | 1.65914730 |
| 156 | Fibular hypoplasia (HP:0003038) | 1.65869927 |
| 157 | Median cleft lip (HP:0000161) | 1.65738924 |
| 158 | Corneal dystrophy (HP:0001131) | 1.65507629 |
| 159 | Lower limb amyotrophy (HP:0007210) | 1.65275105 |
| 160 | Ectopic kidney (HP:0000086) | 1.64433505 |
| 161 | Thin bony cortex (HP:0002753) | 1.63532724 |
| 162 | Cervical subluxation (HP:0003308) | 1.62133203 |
| 163 | Cranial hyperostosis (HP:0004437) | 1.61804834 |
| 164 | Accelerated skeletal maturation (HP:0005616) | 1.61602998 |
| 165 | Xerostomia (HP:0000217) | 1.61387454 |
| 166 | Hypoplastic ischia (HP:0003175) | 1.60539084 |
| 167 | Prominent supraorbital ridges (HP:0000336) | 1.60131851 |
| 168 | Hyperkalemia (HP:0002153) | 1.59716905 |
| 169 | Long nose (HP:0003189) | 1.59537825 |
| 170 | Infantile muscular hypotonia (HP:0008947) | 1.59260571 |
| 171 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.58701722 |
| 172 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.58701722 |
| 173 | Hyperextensible skin (HP:0000974) | 1.58458652 |
| 174 | Abnormality of primary teeth (HP:0006481) | 1.57938207 |
| 175 | Advanced eruption of teeth (HP:0006288) | 1.57905866 |
| 176 | Follicular hyperkeratosis (HP:0007502) | 1.57597014 |
| 177 | Scapular winging (HP:0003691) | 1.57592063 |
| 178 | Dyschromatopsia (HP:0007641) | 1.57422280 |
| 179 | Primary atrial arrhythmia (HP:0001692) | 1.56737236 |
| 180 | Persistence of primary teeth (HP:0006335) | 1.56258414 |
| 181 | Abnormality of salivation (HP:0100755) | 1.55965122 |
| 182 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.55692235 |
| 183 | Abnormality of chromosome stability (HP:0003220) | 1.55599958 |
| 184 | Prolonged bleeding time (HP:0003010) | 1.55139391 |
| 185 | Truncal ataxia (HP:0002078) | 1.53626570 |
| 186 | Drooling (HP:0002307) | 1.53253956 |
| 187 | Excessive salivation (HP:0003781) | 1.53253956 |
| 188 | Cardiovascular calcification (HP:0011915) | 1.53207208 |
| 189 | Lymphangioma (HP:0100764) | 1.52758429 |
| 190 | Prolonged QT interval (HP:0001657) | 1.52006575 |
| 191 | Soft skin (HP:0000977) | 1.51736568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 3.73659333 |
| 2 | CASK | 3.53988349 |
| 3 | INSRR | 3.37433556 |
| 4 | CAMK1G | 2.99325293 |
| 5 | RIPK1 | 2.77986705 |
| 6 | TRIB3 | 2.70523856 |
| 7 | EIF2AK2 | 2.62470504 |
| 8 | IRAK3 | 2.48011344 |
| 9 | EEF2K | 2.34079996 |
| 10 | TNIK | 2.32872229 |
| 11 | MAP3K14 | 2.27504693 |
| 12 | PDGFRA | 2.15503362 |
| 13 | LATS2 | 2.14509657 |
| 14 | TXK | 1.99118017 |
| 15 | ICK | 1.97307402 |
| 16 | ZAK | 1.91479614 |
| 17 | PRPF4B | 1.83405176 |
| 18 | MARK1 | 1.76264107 |
| 19 | GRK1 | 1.68388411 |
| 20 | SIK1 | 1.67710835 |
| 21 | NUAK1 | 1.67027330 |
| 22 | IRAK4 | 1.65325932 |
| 23 | DDR2 | 1.59969188 |
| 24 | ERN1 | 1.56718835 |
| 25 | SIK3 | 1.53709696 |
| 26 | PRKAA2 | 1.52079645 |
| 27 | PDGFRB | 1.46392354 |
| 28 | NTRK1 | 1.45777509 |
| 29 | YES1 | 1.43349693 |
| 30 | JAK1 | 1.41989369 |
| 31 | FRK | 1.41690136 |
| 32 | NEK9 | 1.41080873 |
| 33 | TTN | 1.36674587 |
| 34 | PKN1 | 1.32081066 |
| 35 | NTRK3 | 1.29267558 |
| 36 | TNK2 | 1.27579756 |
| 37 | SGK2 | 1.25748666 |
| 38 | MAPK15 | 1.18958435 |
| 39 | MTOR | 1.18042673 |
| 40 | IRAK2 | 1.17492405 |
| 41 | IRAK1 | 1.17107376 |
| 42 | MAP2K7 | 1.16538413 |
| 43 | MAP3K9 | 1.14184554 |
| 44 | PINK1 | 1.14160113 |
| 45 | CDK3 | 1.13309250 |
| 46 | RET | 1.12989610 |
| 47 | PIK3CA | 1.12090699 |
| 48 | CDK9 | 1.10952357 |
| 49 | BRD4 | 1.09778153 |
| 50 | MYLK | 1.09570820 |
| 51 | ADRBK2 | 1.09216875 |
| 52 | FGFR4 | 1.08870612 |
| 53 | RIPK4 | 1.08304192 |
| 54 | MET | 1.06231158 |
| 55 | MKNK2 | 1.06150693 |
| 56 | IKBKE | 1.04152183 |
| 57 | PTK2 | 1.01597164 |
| 58 | TEC | 1.01151332 |
| 59 | PHKG1 | 1.00343913 |
| 60 | PHKG2 | 1.00343913 |
| 61 | LATS1 | 0.98573416 |
| 62 | NEK6 | 0.98217005 |
| 63 | TGFBR2 | 0.97841064 |
| 64 | MAPK7 | 0.97663572 |
| 65 | IKBKB | 0.95628226 |
| 66 | PDPK1 | 0.95256100 |
| 67 | SIK2 | 0.93400097 |
| 68 | MAPK13 | 0.92817484 |
| 69 | STK38 | 0.92638522 |
| 70 | PRKD3 | 0.92038969 |
| 71 | CDC42BPA | 0.90600692 |
| 72 | DMPK | 0.89309886 |
| 73 | PNCK | 0.87930131 |
| 74 | SGK1 | 0.87043526 |
| 75 | BMPR2 | 0.86522694 |
| 76 | JAK3 | 0.85521884 |
| 77 | MAP2K4 | 0.84608804 |
| 78 | CDK12 | 0.83303371 |
| 79 | MAP3K13 | 0.82013417 |
| 80 | PAK2 | 0.81396492 |
| 81 | TYRO3 | 0.81234564 |
| 82 | FGFR3 | 0.80158722 |
| 83 | PRKCE | 0.79782030 |
| 84 | MAP3K2 | 0.79374833 |
| 85 | BCR | 0.78923092 |
| 86 | PIK3CG | 0.78652183 |
| 87 | MAP3K6 | 0.78067313 |
| 88 | CHUK | 0.76437703 |
| 89 | TRPM7 | 0.76430170 |
| 90 | CAMK1 | 0.76391170 |
| 91 | MST1R | 0.76267078 |
| 92 | MUSK | 0.75465312 |
| 93 | PKN2 | 0.75437219 |
| 94 | STK39 | 0.75300434 |
| 95 | GRK7 | 0.74847721 |
| 96 | SGK223 | 0.74811676 |
| 97 | SGK494 | 0.74811676 |
| 98 | FGFR2 | 0.74801207 |
| 99 | SGK3 | 0.74756294 |
| 100 | RPS6KA2 | 0.74365411 |
| 101 | MAP2K1 | 0.71938454 |
| 102 | HIPK2 | 0.71682405 |
| 103 | EPHB2 | 0.71492434 |
| 104 | TIE1 | 0.70609903 |
| 105 | MAPK4 | 0.67449489 |
| 106 | BMPR1B | 0.67253701 |
| 107 | CDK5 | 0.67027593 |
| 108 | KSR2 | 0.66248010 |
| 109 | TAOK3 | 0.65236996 |
| 110 | UHMK1 | 0.64867395 |
| 111 | PRKAA1 | 0.64299460 |
| 112 | NTRK2 | 0.64134477 |
| 113 | CAMKK1 | 0.63533238 |
| 114 | STK3 | 0.62118056 |
| 115 | PAK6 | 0.61845331 |
| 116 | LMTK2 | 0.60114923 |
| 117 | CLK1 | 0.59143972 |
| 118 | MAPK11 | 0.58744802 |
| 119 | WNK4 | 0.58515240 |
| 120 | DAPK2 | 0.57084502 |
| 121 | MAPKAPK3 | 0.56920074 |
| 122 | OBSCN | 0.56452795 |
| 123 | MAPK10 | 0.56153279 |
| 124 | STK16 | 0.56003728 |
| 125 | WNK1 | 0.55549559 |
| 126 | KIT | 0.55455840 |
| 127 | PRKD1 | 0.54867752 |
| 128 | AKT3 | 0.54627453 |
| 129 | PDK1 | 0.54535971 |
| 130 | CSF1R | 0.54280527 |
| 131 | RPS6KA3 | 0.53645787 |
| 132 | NLK | 0.53001871 |
| 133 | STK38L | 0.51285239 |
| 134 | FER | 0.50883058 |
| 135 | PRKD2 | 0.50727546 |
| 136 | HCK | 0.50567133 |
| 137 | EPHA3 | 0.49556174 |
| 138 | EPHB1 | 0.49462139 |
| 139 | MARK2 | 0.49059389 |
| 140 | PRKG1 | 0.49051117 |
| 141 | EPHA4 | 0.48106067 |
| 142 | PDK2 | 0.47383593 |
| 143 | PRKCQ | 0.47058530 |
| 144 | ROCK1 | 0.47027581 |
| 145 | PRKACG | 0.46169849 |
| 146 | MAP3K7 | 0.44673889 |
| 147 | MAPK12 | 0.44656880 |
| 148 | CAMK4 | 0.43538284 |
| 149 | IGF1R | 0.43328909 |
| 150 | LYN | 0.41313069 |
| 151 | INSR | 0.41092940 |
| 152 | ABL1 | 0.38913121 |
| 153 | PRKCH | 0.37969353 |
| 154 | MAP3K4 | 0.37344730 |
| 155 | LCK | 0.36320352 |
| 156 | CSK | 0.35875318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.10157873 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.83471536 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.85303382 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.82371500 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 1.78625635 |
| 6 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.74832611 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.69480227 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.67048305 |
| 9 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.65692748 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.64791623 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64375546 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62487127 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62237051 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.61762736 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.60107943 |
| 16 | Bile secretion_Homo sapiens_hsa04976 | 1.54368894 |
| 17 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.43727125 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40438178 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.37802356 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34381232 |
| 21 | ABC transporters_Homo sapiens_hsa02010 | 1.28225842 |
| 22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28007711 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.24935965 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.24001444 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22892805 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21772889 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.19571372 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19564030 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.18657066 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.18581729 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.17205128 |
| 32 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.17033784 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16650584 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.16297516 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15947611 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14831449 |
| 37 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.14693947 |
| 38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.13267714 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.13120471 |
| 40 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.09714224 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.08600347 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08518350 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07913415 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 1.06612240 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05920015 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04888496 |
| 47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.03795098 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02438353 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.01484795 |
| 50 | Malaria_Homo sapiens_hsa05144 | 1.00409462 |
| 51 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.00229017 |
| 52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99737805 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99197377 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.99185978 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98330469 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97934198 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 0.97796941 |
| 58 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.97611445 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97361006 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96556020 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96093829 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.95624869 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94952621 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.94893513 |
| 65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94590586 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94211517 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.93917397 |
| 68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93914383 |
| 69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93803143 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92807537 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.92475816 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92469652 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91340585 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90733197 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89031695 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87802006 |
| 77 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87595943 |
| 78 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.87253141 |
| 79 | Long-term potentiation_Homo sapiens_hsa04720 | 0.86541975 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85197222 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84907364 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84297960 |
| 83 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83898945 |
| 84 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.82189611 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82075154 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81683951 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81682861 |
| 88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.81400129 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.81397140 |
| 90 | Asthma_Homo sapiens_hsa05310 | 0.80607183 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79003457 |
| 92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78808514 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78347504 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77687676 |
| 95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77475085 |
| 96 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75911875 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75619386 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75572446 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.74977457 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74812832 |
| 101 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74266117 |
| 102 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73999334 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.73734296 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73693459 |
| 105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73416064 |
| 106 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73102553 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.72337467 |
| 108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71466069 |
| 109 | Melanogenesis_Homo sapiens_hsa04916 | 0.70936221 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70306010 |
| 111 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70105023 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69879132 |
| 113 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.68028578 |
| 114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67597272 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67547945 |
| 116 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65946872 |
| 117 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64563760 |
| 118 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64511834 |
| 119 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64420215 |
| 120 | Melanoma_Homo sapiens_hsa05218 | 0.64242600 |
| 121 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.64224220 |
| 122 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62338340 |
| 123 | Gap junction_Homo sapiens_hsa04540 | 0.62171682 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61886696 |
| 125 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61731938 |
| 126 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61388934 |
| 127 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61362755 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.61108757 |
| 129 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60808892 |
| 130 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59969160 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59800992 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.59411224 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57877975 |
| 134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57419363 |
| 135 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57303691 |
| 136 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.56288433 |
| 137 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.56104374 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55979154 |
| 139 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55776162 |
| 140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55496256 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.55307227 |
| 142 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55298462 |
| 143 | Long-term depression_Homo sapiens_hsa04730 | 0.55025030 |
| 144 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54528711 |
| 145 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54467648 |
| 146 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54358660 |
| 147 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53902603 |
| 148 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52924021 |
| 149 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52823500 |
| 150 | Hepatitis C_Homo sapiens_hsa05160 | 0.52611965 |
| 151 | Influenza A_Homo sapiens_hsa05164 | 0.52573614 |
| 152 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52545256 |
| 153 | Insulin resistance_Homo sapiens_hsa04931 | 0.52423364 |
| 154 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51980700 |
| 155 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51718010 |
| 156 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51149390 |
| 157 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50732740 |
| 158 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50074338 |
| 159 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49710898 |
| 160 | GABAergic synapse_Homo sapiens_hsa04727 | 0.49676095 |

